Clarius Group LLC’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
14,970
+1,689
| +13% | +$117K | 0.06% | 142 |
|
|
2025
Q1 | $922K | Buy |
13,281
+2,351
| +22% | +$163K | 0.06% | 154 |
|
|
2024
Q4 | $940K | Sell |
10,930
-2,762
| -20% | -$238K | 0.06% | 133 |
|
|
2024
Q3 | $1.41M | Sell |
13,692
-1,191
| -8% | -$123K | 0.1% | 93 |
|
|
2024
Q2 | $2.12M | Sell |
14,883
-2,384
| -14% | -$340K | 0.15% | 67 |
|
|
2024
Q1 | $2.22M | Sell |
17,267
-1,238
| -7% | -$159K | 0.15% | 65 |
|
|
2023
Q4 | $1.91M | Buy |
18,505
+93
| +0.5% | +$9.62K | 0.16% | 73 |
|
|
2023
Q3 | $1.67M | Sell |
18,412
-1,014
| -5% | -$92.2K | 0.16% | 74 |
|
|
2023
Q2 | $1.57M | Buy |
19,426
+82
| +0.4% | +$6.64K | 0.12% | 93 |
|
|
2023
Q1 | $1.54M | Buy |
19,344
+186
| +1% | +$14.8K | 0.13% | 91 |
|
|
2022
Q4 | $1.3M | Sell |
19,158
-156
| -0.8% | -$10.6K | 0.12% | 103 |
|
|
2022
Q3 | $962K | Buy |
19,314
+4,324
| +29% | +$215K | 0.1% | 122 |
|
|
2022
Q2 | $835K | Buy |
14,990
+2,930
| +24% | +$163K | 0.08% | 146 |
|
|
2022
Q1 | $675K | Hold |
12,060
| – | – | 0.05% | 187 |
|
|
2021
Q4 | $675K | Buy |
12,060
+1,472
| +14% | +$82.4K | 0.05% | 187 |
|
|
2021
Q3 | $508K | Buy |
10,588
+106
| +1% | +$5.09K | 0.05% | 211 |
|
|
2021
Q2 | $439K | Buy |
10,482
+1,636
| +18% | +$68.5K | 0.04% | 237 |
|
|
2021
Q1 | $298K | Sell |
8,846
-710
| -7% | -$23.9K | 0.03% | 289 |
|
|
2020
Q4 | $334K | Buy |
9,556
+776
| +9% | +$27.1K | 0.04% | 239 |
|
|
2020
Q3 | $305K | Hold |
8,780
| – | – | 0.04% | 210 |
|
|
2020
Q2 | $287K | Buy |
8,780
+264
| +3% | +$8.63K | 0.04% | 218 |
|
|
2020
Q1 | $256K | Sell |
8,516
-4
| -0% | -$120 | 0.05% | 200 |
|
|
2019
Q4 | $266K | Buy |
8,520
+170
| +2% | +$5.31K | 0.04% | 229 |
|
|
2019
Q3 | $216K | Buy |
+8,350
| New | +$216K | 0.04% | 255 |
|